Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells

Microbial Pathogenesis

Volumn 69-70, Issue 1, 2014, Pages 20-27

  Orsi, Carlotta F ^a,b   Borghi, Elisa ^a   Colombari, Bruna ^b   Neglia, Rachele G ^b   Quaglino, Daniela ^b   Ardizzoni, Andrea ^b   Morace, Giulia ^a   Blasi, Elisabetta ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Biofilm; Candida albicans; Hyphal wall protein 1 (HWP1) genotype; Microglial cells

Indexed keywords

ADHESIN; MESSENGER RNA; FUNGAL PROTEIN; HYPHAL WALL PROTEIN 1; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HWP1 PROTEIN, CANDIDA ALBICANS; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL DAMAGE; CELL GRANULE; CELL SHAPE; CELL WALL; CONTROLLED STUDY; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HWP1 GENE; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; CELL FUNCTION; CELL STRUCTURE; FUNGAL CELL WALL; FUNGUS HYPHAE; FUNGUS ISOLATION; GENE EXPRESSION; HOST SUSCEPTIBILITY; IMMUNOCOMPETENT CELL; MICROBIAL ADHESION; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY;

CANDIDA ALBICANS;

BIOFILMS; CANDIDA ALBICANS; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENOTYPE; HYPHAE; MEMBRANE GLYCOPROTEINS; MICROBIAL VIABILITY; MICROGLIA; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921951371     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.03.003     Document Type: Article

References (42)

1. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163. 10.1038/nport.2008.141.
2. Gullo A. Invasive fungal infections: the challenge continues. Drugs 2009, 69:65-73. 10.2165/11315530-000000000-00000.
3. Cahan H., Deville J.G. Outcomes of neonatal candidiasis: the impact of delayed initiation of antifungal therapy. Int J Pediatr 2011, 2011:813871. 10.1155/2011/813871.
4. Ramage G., Martínez J.P., López-Ribot J.L. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006, 6:979-986. 10.1111/j.1567-1364.2006.00117.x.
5. Wenzel R.P., Edmond M.B. The evolving technology of venous access. NEngl J Med 1999, 340:48-50. 10.1056/NEJM199901073400109.
6. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 2004, 17:255-267.
7. Sánchez-Portocarrero J., Martín-Rabadán P., Saldaña C.J., Pérez-Cecilia E. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis 1994, 20:33-40.
8. Ramage G., Saville S.P., Thomas D.P., López-Ribot J.L. Candida biofilms: an update. Eukaryot Cell 2005, 4:633-638. 10.1128/EC.4.4.633-638.2005.
9. Kumamoto C.A., Vinces M.D. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 2005, 59:113-133. 10.1146/annurev.micro.59.030804.121034.
10. Katragkou A., Kruhlak M.J., Simitsopoulou M., Chatzimoschou A., Taparkou A., Cotten C.J., et al. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. JInfect Dis 2010, 201:1941-1949. 10.1086/652783.
11. Cirasola D., Sciota R., Vizzini L., Ricucci V., Morace G., Borghi E. Experimental biofilm-related Candida infections. Future Microbiol 2013, 8:799-805. 10.2217/fmb.13.36.
12. Mazaheritehrani E., Sala A., Orsi C.F., Neglia R.G., Morace G., Blasi E., et al. Human pathogenic viruses are retained in and released by Candida albicans biofilm invitro. Virus Res 2014, 179:153-160. 10.1016/j.virusres.2013.10.018.
13. Nobile C.J., Mitchell A.P. Regulation of cell-surface genes and biofilm formation by the C.albicans transcription factor Bcr1p. Curr Biol CB 2005, 15:1150-1155. 10.1016/j.cub.2005.05.047.
14. Thomas D.P., Bachmann S.P., Lopez-Ribot J.L. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics 2006, 6:5795-5804. 10.1002/pmic.200600332.
15. Harriott M.M., Lilly E.A., Rodriguez T.E., Fidel P.L., Noverr M.C. Candida albicans forms biofilms on the vaginal mucosa. Microbiol Read Engl 2010, 156:3635-3644. 10.1099/mic.0.039354-0.
16. Nobile C.J., Andes D.R., Nett J.E., Smith F.J., Yue F., Phan Q.-T., et al. Critical role of Bcr1-dependent adhesins in C.albicans biofilm formation invitro and invivo. PLoS Pathog 2006, 2:e63. 10.1371/journal.ppat.0020063.
17. Nobile C.J., Nett J.E., Andes D.R., Mitchell A.P. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006, 5:1604-1610. 10.1128/EC.00194-06.
18. Staab J.F., Bradway S.D., Fidel P.L., Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999, 283:1535-1538.
19. Sundstrom P., Balish E., Allen C.M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. JInfect Dis 2002, 185:521-530. 10.1086/338836.
20. Naglik J.R., Fostira F., Ruprai J., Staab J.F., Challacombe S.J., Sundstrom P. Candida albicans HWP1 gene expression and host antibody responses in colonization and disease. JMed Microbiol 2006, 55:1323-1327. 10.1099/jmm.0.46737-0.
21. Biswas S., Van Dijck P., Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 2007, 71:348-376. 10.1128/MMBR.00009-06.
22. Chaffin W.L. Candida albicans cell wall proteins. Microbiol Mol Biol Rev MMBR 2008, 72:495-544. 10.1128/MMBR.00032-07.
23. Finkel J.S., Mitchell A.P. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol Feb 2011, 9(2):109-118. 10.1038/nrmicro2475.
24. de Groot P.W.J., Bader O., de Boer A.D., Weig M., Chauhan N. Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot Cell 2013, 12:470-481. 10.1128/EC.00364-12.
25. Tsuchimori N., Sharkey L.L., Fonzi W.A., French S.W., Edwards J.E., Filler S.G. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun 2000, 68:1997-2002.
26. Blasi E., Mazzolla R., Pitzurra L., Barluzzi R., Bistoni F. Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans. Antimicrob Agents Chemother 1993, 37:2422-2426.
27. Blasi E., Pitzurra L., Puliti M., Mazzolla R., Barluzzi R., Saleppico S., et al. Different events involved in the induction of macrophage tumor necrosis factor by Candida albicans and lipopolysaccharide. Cell Immunol 1994, 157:501-509. 10.1006/cimm.1994.1245.
28. Blasi E., Mazzolla R., Barluzzi R., Bistoni F. Microglial cell-mediated anti-Candida activity: temperature, ions, protein kinase C as crucial elements. JNeuroimmunol 1991, 34:53-60.
29. Blasi E., Mucci A., Neglia R., Pezzini F., Colombari B., Radzioch D., et al. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol Med Microbiol 2005, 44:69-79.
30. Puliti M., Radzioch D., Mazzolla R., Barluzzi R., Bistoni F., Blasi E. Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans. Infect Immun 1995, 63:4170-4173.
31. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. JNeuroimmunol 1990, 27:229-237.
32. Blasi E., Pitzurra L., Puliti M., Lanfrancone L., Bistoni F. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun 1992, 60:832-837.
33. Neglia R., Colombari B., Peppoloni S., Orsi C., Tavanti A., Senesi S., et al. Adaptive response of microglial cells to invitro infection by Candida albicans isolates with different genomic backgrounds. Microb Pathog 2006, 41:251-256. 10.1016/j.micpath.2006.08.001.
34. McCluskey K. The fungal genetics stock Center: from molds to molecules. Adv Appl Microbiol 2003, 52:245-262.
35. Morace G., Borghi E., Iatta R., Amato G., Andreoni S., Brigante G., et al. Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients. BMC Infect Dis 2011, 11:130. 10.1186/1471-2334-11-130.
36. Padovan A.C.B., Chaves G.M., Colombo A.L., Briones M.R.S. Anovel allele of HWP1, isolated from a clinical strain of Candida albicans with defective hyphal growth and biofilm formation, has deletions of Gln/Pro and Ser/Thr repeats involved in cellular adhesion. Med Mycol Off Publ Int Soc Hum Anim Mycol 2009, 47:824-835. 10.3109/13693780802669574.
37. Pierce C.G., Uppuluri P., Tristan A.R., Wormley F.L., Mowat E., Ramage G., et al. Asimple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008, 3:1494-1500. 10.1038/nport.2008.141.
38. Quaglino D., Ha H.R., Duner E., Bruttomesso D., Bigler L., Follath F., et al. Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship. Am J Physiol Lung Cell Mol Physiol 2004, 287:L438-L447. 10.1152/ajplung.00434.2003.
39. Chandra J., McCormick T.S., Imamura Y., Mukherjee P.K., Ghannoum M.A. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C.albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun 2007, 75:2612-2620. 10.1128/IAI.01841-06.
40. Plaine A., Walker L., Da Costa G., Mora-Montes H.M., McKinnon A., Gow N.A.R., et al. Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol 2008, 45:1404-1414. 10.1016/j.fgb.2008.08.003.
41. Balish E., Warner T., Pierson C.J., Bock D.M., Wagner R.D. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med Mycol Off Publ Int Soc Hum Anim Mycol 2001, 39:261-268.
42. Sundstrom P., Cutler J.E., Staab J.F. Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect Immun 2002, 70:3281-3283. 10.1086/338836.